ArticleCancer medicine2026
Development of a Machine Learning-Based Predictive Model for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCentral lymph nodes metastasis (CLNM) is common in papillary thyroid. Microcarcinoma (PTMC). Whilst prophylactic central lymph node dissection (CLND) can prevent further CLNM, it remains controversial. An accurate model to predict CLNM is therefore necessary for patients with PTMC.
methodsThis study incorporated 228 patients with general clinical information, thyroid related serological examination and ultrasound of CLNM prediction, divided into training and validation sets randomly at 7:3 ratio. Least Absolute Shrinkage and Selection Operator (LASSO) regression was used for key features screening. Eight machine learning models were developed, evaluated by cross-validation and performance comparison (the area under curve, calibration curve and decision curve analysis). Shapley Additive exPlanations (SHAP) value analysis provided the interpretability of the model.
resultsAge, gender, tumor diameter, T3, T4, TPOAb and ultrasound of CLNM prediction were identified as key features of CLNM in patients. Support Vector Machine (SVM) model with 0.783 accuracy and 0.805 specificity in validation set was considered as the most favorable performance. Age, gender and tumor diameter were the top three contributing variables in SVM model.
conclusionThis study established a machine learning-based framework for predicting CLNM in PTMC, with the SVM model demonstrating superior stability and clinical utility among the evaluated algorithms. While these results are preliminary, they provide a promising tool to assist in tailoring prophylactic CLND strategies, potentially reducing unnecessary surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.